Scynexis Inc (SCYX) vs. Its Peers: A Comparison

Scynexis Inc (NASDAQ: SCYX) has a price-to-earnings ratio of 1.57x that is above its average ratio. Additionally, the 36-month beta value for SCYX is 1.56. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 3 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”

The public float for SCYX is 35.77M and currently, short sellers hold a 2.64% ratio of that float. The average trading volume of SCYX on April 04, 2024 was 197.62K shares.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


SCYX) stock’s latest price update

Scynexis Inc (NASDAQ: SCYX)’s stock price has soared by 24.14 in relation to previous closing price of 1.45. Nevertheless, the company has seen a gain of 29.50% in its stock price over the last five trading days. GlobeNewsWire reported 2024-01-05 that JERSEY CITY, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of preclinical efficacy data on its second generation fungerp candidate SCY-247 for the treatment of mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis (AAAM) Conference in Milan, Italy from January 25 – 27, 2024.

SCYX’s Market Performance

Scynexis Inc (SCYX) has experienced a 29.50% rise in stock performance for the past week, with a 10.43% rise in the past month, and a -18.55% drop in the past quarter. The volatility ratio for the week is 10.18%, and the volatility levels for the past 30 days are at 7.18% for SCYX. The simple moving average for the past 20 days is 19.62% for SCYX’s stock, with a -19.16% simple moving average for the past 200 days.

Analysts’ Opinion of SCYX

Many brokerage firms have already submitted their reports for SCYX stocks, with Guggenheim repeating the rating for SCYX by listing it as a “Buy.” The predicted price for SCYX in the upcoming period, according to Guggenheim is $25 based on the research report published on January 22, 2021 of the previous year 2021.

Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see SCYX reach a price target of $30. The rating they have provided for SCYX stocks is “Overweight” according to the report published on January 06th, 2021.

Needham gave a rating of “Buy” to SCYX, setting the target price at $5 in the report published on July 11th of the previous year.

SCYX Trading at 5.70% from the 50-Day Moving Average

After a stumble in the market that brought SCYX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.49% of loss for the given period.

Volatility was left at 7.18%, however, over the last 30 days, the volatility rate increased by 10.18%, as shares surge +9.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.17% lower at present.

During the last 5 trading sessions, SCYX rose by +29.50%, which changed the moving average for the period of 200-days by -34.31% in comparison to the 20-day moving average, which settled at $1.5122. In addition, Scynexis Inc saw -19.28% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for SCYX

Current profitability levels for the company are sitting at:

  • 0.52 for the present operating margin
  • 0.89 for the gross margin

The net margin for Scynexis Inc stands at 0.32. The total capital return value is set at 0.65. Equity return is now at value 175.97, with 62.01 for asset returns.

Based on Scynexis Inc (SCYX), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at 4.81. The debt to equity ratio resting at 0.17. The interest coverage ratio of the stock is 20.72.

Currently, EBITDA for the company is 73.48 million with net debt to EBITDA at -0.27. When we switch over and look at the enterprise to sales, we see a ratio of 0.35. The receivables turnover for the company is 6.42for trailing twelve months and the total asset turnover is 1.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.26.


In conclusion, Scynexis Inc (SCYX) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts